Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-13 · accession 0001815638-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-17 | 2025-11-13+ | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $9.12 | +3,700 | 24.9K | +17% | +$33.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | P | A | 1,000 | $9.18 | 22,239 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-17 | P | A | 2,700 | $9.10 | 24,939 | D | — | — |